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C57BL/6J, CD4Cre mice (1), C57BL/6-Tg(Tcra2D2,Tcrb2D2)1Kuch/J (named 2D2tg) mice (2), and 
B6.129 S(FVB)-Bcl6tm1.1Dent/J (named Bcl6flox or Bcl6fl/fl) mice (3) were purchased from the Jackson 
laboratories. The breeding strategies of the CD4CreBcl6fl/fl2D2tg and CD4CreBcl6fl/fl strains were 
described previously (4). Animal research protocols were approved by the responsible state 
authorities (Landesamt für Natur, Umwelt und Verbraucherschutz (LANUV), English: ‘State Agency 
for Nature, Environment and Consumer Protection’ of the German state North Rhine-Westphalia 
(NRW)) under reference number 84-02.04.2015.A319 and were performed in accordance with local 
regulations from the “Tierschutzbüro der Medizinischen Fakultät der Westfälischen Wilhelms-
Universitat Münster” (English: Animal Protection Office of the Medical Faculty of the Westfälische 
Wilhelms-University Münster). Mice of both sexes were used (age 8-14 weeks). Igh-Jtm1Aigl mice 
(synonymously named TH mice or IgHMOG mice; (5)) were used for B cell proliferation in in vitro 
experiments.  
 
Adoptive transfer (AT) experimental autoimmune encephalomyelitis (EAE) and active EAE 
Adoptive transfer EAE was induced as described (6). Briefly, naïve CD44lowCD62Lhigh CD4+ T cells 
were sorted from 2D2tg donor mice and cultured for 2 days at 2x106 cells/ml in the presence of 
irradiated antigen presenting cells in medium containing soluble anti-CD3 antibody (2.5 µg/ml), IL-
6 (20 ng/ml), TGF-β1 (10 ng/ml) and anti-IFNγ antibody (10 μg/ml) (all cytokines from R&D). Cells 
were subsequently split when necessary and cultured in IL-23 (10 ng/ml) containing medium for 3 
additional days. Cells were then resuspended in medium containing soluble anti-CD28 antibody (2 
µg/ml) and plated at a concentration of 2x106 cells/ml on anti-CD3 (2 µg/ml) coated plates in the 
absence of cytokines for 2 days. 5x106 cells were then intravenously injected into young adult 
C57BL/6 recipient mice. Recipient mice were monitored daily and an ataxia score was calculated 
by assessing the following criteria: ledge test, hindlimb clasping, gait and kyphosis (7). Each criteria 
was rated on a scale from 0 (healthy) to 3 and all points were added up to a maximum ataxia score 
of 12 as described (4). Active EAE was induced with a subcutaneous injection of MOG35-55 peptide 
(200 µg/mouse, Charité, Berlin) and Mycobacterium tuberculosis H37Ra extract (1 mg/ml, BD) in 
complete Freund’s adjuvant (200 µl/mouse). EAE mice were clinically monitored as described 
previously (4). 
 
Leukocyte isolation from CNS 
Labeling of blood leukocytes to identify tissue-resident leukocytes (TRL) was performed by 
intravenous injection of fluorescence coupled anti-CD45.2 antibody (clone 104, Biolegend, 3 
µg/mouse) into the tail vein of mice as described (8). Five minutes after antibody injection, animals 
were anesthetized with Ketamine / Xylazine and intracardially perfused with cold phosphate-
buffered saline (PBS) with 10 U/ml heparin.  
For separate isolation of the parenchymal and the meningeal tissue of the spinal cord (SC), SC 
parenchyma was flushed out from the spinal canal with hydrostatic pressure after removing the 
brain. The SC meninges remained attached to the vertebrae and were then peeled off the vertebrae 
under a binocular. Spinal nerves and ganglia were removed from meningeal tissue using fine 
forceps.  
Parenchymal SC tissue was cut up and then digested with collagenase D (2.5 mg/ml, Roche 
Diagnostics) and DNase I (0.05 mg/ml, Sigma) for 20 min at 37 °C. Meningeal tissue was digested 
under continuous shaking in PBS with 1 mg/ml collagenase D for 45 min at 37°C. The digested 
tissue was passed through a 40 µm cell strainer. Parenchymal homogenates were layered on a 





washed and purified cells were subsequently stained for flow cytometry or fluorescence activated 
cell sorting (FACS) for scRNA-seq into FCS-coated tubes or for bulk RNA sequencing into RNA 
lysis buffer. 
 
Flow cytometry analysis and FACS 
Cells were stained for flow cytometry or FACS for 30 min at room temperature with anti-mouse 
antibodies (clone names in brackets, BioLegend unless indicated otherwise): CD45 (30-11 F), CD3 
(17A2), CD4 (RM4-5 or GK1.5), TCR Vβ11 (KT11), CD19 (6D5), CD11b (M1/70); live/dead staining 
was performed with “Zombie NIR” (1:500). To quantify cytokine production, cells were resuspended 
in culture medium containing 20 ng/ml PMA, 500 ng/ml ionomycin, GolgiStop, and GolgiPlug (BD, 
each 1:1000 diluted). After 4 h of incubation at 37 °C, cells were stained extracellularly, fixed, and 
permeabilized using the Cytofix/Cytoperm kit (BD) according to the manufacturer’s protocol. Then, 
IL-17A (eBioscience, eBio17B7) and IFN-γ (XMG1.2) were stained intracellularly. After staining, 
cells were washed twice and resuspended in MACS buffer (PBS with 0.5% BSA, 2mM EDTA, pH 
= 7.2). Cells were acquired using a Gallios (Beckman Coulter) flow cytometer, or a FACSCelesta 
flow cytometer (Becton Dickinson) or sorted on a BD FACS Aria III cell sorter using FACS Diva 
software following manufacturer’s recommended settings. Sorting of viable tissue-resident 
leukocytes - either CD45high leukocytes or Vβ11+ CD4+ T cells - was performed using an 85 µm 
nozzle and the sort precision mode “purity”. Flow cytometry data were analyzed using FlowJo 
software v10.7.0_CL.  
 
Single cell RNA-sequencing (scRNA-seq) - Generation of single cell libraries, sequencing, and 
preprocessing of sequencing data. 
Single cell suspensions were loaded onto the Chromium Single Cell Controller using the Chromium 
Single Cell 3' Library & Gel Bead Kit (both from 10X Genomics) with v3 chemistry. Sample 
processing and library preparation was performed according to manufacturer's instructions using 
AMPure beads (Beckman Coulter). In order to avoid batch effects, all four samples (Dataset S1) 
were processed on the same day with the same chip. The rest of cDNA was used for single cell 
TCR sequencing (see below). Sequencing was carried out commercially on an Illumina Novaseq 
with 150-8-8-150 read setup. Details regarding sequencing depth and cell recovery are provided in 
Dataset S1. Processing of sequencing data was performed with the cellranger pipeline v3.0.2 (10X 
Genomics) according to the manufacturer’s instructions. Briefly, subsequent read alignments and 
transcript counting was done individually for each sample using the cellranger count pipeline with 
standard parameters. The cellranger aggr pipeline was employed to aggregate samples with 
mapping normalization to leave each sample with similar sequencing depth per cell. The total cell 
number was 22,700 with an average of 5675 ± 190 SEM cells per sample used for analysis (Dataset 
S1).  
 
Single cell RNA-sequencing clustering and differential expression (DE) analysis 
Unbiased cell type clustering was performed in the combined sample (wt-R-men, wt-R-par, 
Bcl6KO-R-men, Bcl6KO-R-par). Downstream analysis was performed with the R-package Seurat 
v3.1.1 (9) using R v3.6.1 as previously described (10). Briefly, low-quality cells and some cell 
doublets were removed by filtering cells with few genes (<500), high number of genes (>4500-
5300) or high mitochondrial percentages (>4.5%). A further doublet depletion was done by R 
package DoubletDecon v1.1.4 (11) with default setting. After QC and doublet removal, the total 
remaining cell number used for further analysis was 16,068 with an average of 4,017 ± 132 SEM 
cells per sample (Dataset S1). Data were normalized using SCTransform (12). Data were 





(PCA) for primary dimensionality reduction to identify the number of principal components for 
further analysis, and we performed an elbow plot.  
PCA results were used for Uniform Manifold Approximation and Projection (UMAP). Clusters were 
identified by the “FindNeighbors” and “FindClusters” functions in Seurat. To better annotate the 
clusters, we queried differentially expressed (DE) genes in a literature search and plotted them in 
feature plots. 
No cell clusters were removed. DE genes were identified by the “FindMarker” function in Seurat. 
DE genes were visualized in volcano plots with the R package EnhancedVolcano (13). DE gene 
lists include all cell clusters consisting of at least 10 cells used for comparison. Positive avg_logFC 
values describe a higher gene expression in the first mentioned of the two compared groups. 
DotPlots and FeaturePlots were created using the internal visualization functions of Seurat. 
 
Single cell TCR Repertoire sequencing from 3’ single cell cDNA libraries (Circularization scTCR-
seq) 
The method “Circularization scTCR-seq” was recently developed by our group (16) and allowed 
the reconstruction of single cell antigen receptor information in cDNA generated by microfluidics-
based 3’ barcoding scRNA-seq. This was achieved by shortening the constant region of antigen 
receptors during enrichment, while maintaining cell barcode and UMI information attached to the 3' 
end of the cDNA molecules. The sequence of the variable (VDJ) region of TCRs cannot be 
identified from microfluidics-based 3’ scRNA-seq with other approaches by short read sequencers 
such as Illumina’s platform, as the VDJ region is located near the 5’ end of the transcript (14) with 
constant region between VDJ region and 3’ cell barcode. The length of the constant (C) region 
reaches up to 1475 bp (15) and thus exceeds the maximum insert length (~700 bp) of short read 
sequencers (Fig. S3E), therefore no library containing both 3’ barcode and VDJ region sequence 
can be made by other approaches. Our new method allowed shortening the constant region of 
antigen receptors during enrichment, while maintaining their cell barcode and UMI information 
attached to the 3' of the cDNA molecules. In summary, the method used self-circulating the cDNA 
library to ligate the 3’ cell barcode with the 5’ end of the same molecule. To achieve this, the VDJ 
region was enriched together with the cell barcode, then self-circulated again and re-linearized to 
leave read1 at the 5’ end of the enriched fragments. Each step maintains the VDJ region together 
with the cell barcode and UMI in the same molecule (Fig S3E; details below).  
First methods for microfluidics-based scRNA-seq were based on 3’-capturing (17, 18) and the 
ability to reconstruct antigen receptor sequences was achieved later by 5’-capturing (19). We here 
thus introduced an alternative approach (Fig. S3E). We see advantages of this approach, because 
it can reconstruct antigen receptor sequences from ‘older’ existing 3’ libraries, and it is theoretically 
compatible with RNA-capture in spatial transcriptomics.  
Circularization scTCR-seq was performed as previously described (16). In detail, Primer Poly A 
was used as a 5’ race primer and two TCR reverse primer pools were designed according to the 
constant region sequence of the murine TCR. All primers were synthesized by Eurofins Genomics; 
the primer names, sequences and concentrations are listed in Dataset S23. For circularization, 25 
ng of cDNA generated from the Chromium Single Cell 3ʹ GEM Kit v3 (10x Genomics) were end-
phosphated with the T4 Polynucleotide Kinase (New England Biolabs), and purified by 0.6x Ampure 
XP beads (Beckman Coulter). 1,000 units of T4 DNA Ligase (New England Biolabs) were added 
to self-circularize the phosphated cDNA in 25 µl total volume at 16°C for 16 hours. Subsequently, 
0.7x Ampure XP beads were used for cDNA purification. Remaining linear DNA was digested by 
0.9 units/µl RecJf and 0.1 units/µl Lambda Exonuclease (both from New England Biolabs). 
Circularized cDNA libraries were purified by 0.7x Ampure XP beads. A 5’ race nested PCR 
enrichment was performed to enrich the T cell receptor (TCR) variable region. Firstly, with 25 µl 





pool_out (Dataset S23); secondly with 25 µl Kapa hotstart amplification mix, 10 µl primer polyA and 
5 µl primer TCR rev pool_in (Dataset S23). Because Primer Melting Temperatures are very different 
between primer Poly A and TCR rev primers, a 4 steps PCR (including 2 steps of annealing with 
different temperature, see Dataset S23) was used in both PCR steps. 0.5x - 0.8 x Ampure XP 
beads were used for subsequent size selection. Then, 25 ng of the nested PCR product were 
phosphated, circulated and linear digested again as above. A PCR with primers read1 and TSO 
(Dataset S23) was used to re-linearize the circulated library (Fig. S3E). PCR products were purified 
by 0.5x - 0.8 x Ampure XP beads (Beckman Coulter) and libraries were prepared using the 
Chromium Single Cell 3’ Library Kit v3 (10x Genomics). Sequencing was carried out commercially 
on an Illumina Novaseq with 150-8-8-150 read setup. Details regarding sequencing depth and cell 
recovery are provided in Dataset S1. A patent application covering the method for reconstructing 
TCR information from 3’ libraries has been applied under the filing number LU101949. 
The single cell TCR library has similar structures as the 10x Genomics 5’ VDJ kit on read1 data but 
contains the reverse-complement sequence on read2 data. In order to use the cellranger VDJ 
pipeline (10x Genomics) to process our data, a reverse-complement modification of read2 data 
was done by using the SeqKit v0.11.0 (20). Because of the cell barcodes white lists difference 
between the 10x 3’ v3 kit and the 10x 5’ VDJ kit, we also replaced the cell barcodes white list of 
the 5’ VDJ kit with the cell barcodes white list of 10x 3’ v3 kit: In the folder of “/cellranger-
3.1.0/cellranger-cs/3.1.0/lib/python/cellranger/barcodes/”, we unzipped the file “3M-february-
2018.txt.gz”, renamed it as “737K-august-2016.txt” and replaced the same name file in the same 
folder. Processing of modified sequencing data was performed with the modified cellranger VDJ 
pipeline v3.1.0 (10X Genomics) according to the manufacturer’s instructions with default settings.  
In order to filter out possible mismatched cell barcodes during circularization, we introduced two 
filters that combined both scRNA-seq data and circularization scTCR-seq data to define possible 
2D2 mouse derived T cells and confident 2D2 mouse derived T cells: 1) possible 2D2 mouse 
derived T cells using the following criteria: the cells contain any of  CDR3 of 2D2 mouse T cell 
clonotype (TRA: CAVRSYNQGKLIF, TRB: CASSLDPGANTEVFF) in circularized scTCR-seq data 
and have at least 2 counts of total UMI of Trac, Trbc1 and Trbc2 transcripts in scRNAseq data. 2) 
confident 2D2 mouse derived T cells using the following criteria: the cells contain only CDR3 of 
2D2 mouse T cell clonotype (TRA:CAVRSYNQGKLIF, TRB: CASSLDPGANTEVFF) in circularized 
scTCR-seq data and the ratios of their sum UMI count of Trac, Trbc1 and Trbc2 transcripts in the 
total RNA UMI counts are above 0.0025 in the scRNAseq data. We named confident 2D2-derived 
T cells as “2D2” cells and we named cells which do not match the 2D2 sequence as “non-2D2”, 
and we named possible 2D2-derived T cells which are not confident 2D2 mouse derived T cells as 
“uncertain” (Dataset S1). In our scRNA-seq dataset, the known 2D2tg TCR α/β-sequence (2, 21) 
was identified in 30% of all α TCR chains and in 36% of all β TCR chains within the CD4+ T cell 
clusters, respectively (Dataset S7). Single cell transcriptomes were classified as 2D2 when they 
expressed one or both chains of the 2D2tg TCR and expressed the Trac/Trbc mRNA at sufficient 
threshold.  
 
Bulk RNA-seq of sorted Vβ11+ CD4+ T cells 
Bulk RNA-seq was performed from flow sorted Vβ11+CD4+ T cells. These cells were either sorted 
from 1) in vitro differentiated Th17 cells immediately prior to intravenous injection for the induction 
of adoptive transfer (AT-) EAE, or 2) from leukocytes isolated ex vivo from AT-EAE recipient mice 
at peak of disease. Cells were sorted directly into 1.5 ml reaction tubes containing 100 µl RNA Lysis 
Buffer (Zymo Research). After sorting, tubes were vortexed, briefly centrifuged and stored at −80 °C 
until RNA isolation.  
Samples for bulk RNA-seq were prepared using a modified version of the SmartSeq2 protocol (23). 





as input. Reaction volumes were scaled up and the number of PCR cycles during cDNA 
amplification was adjusted accounting for the higher number of input cells compared to the original 
protocol (23). Library Preparation was done by the Next Ultra II FS DNA Library Prep Kit (New 
England Biolabs) using 1–3 ng of cDNA as input following the manufacturer’s instructions. The rest 
of cDNA was kept for qPCR (see below). Sequencing was carried out on a NextSeq500 using the 
High-Out 75 cycle kit (Illumina) with 0-8-8-75 set up. Average read depth was 15.19 ± 0.65 SEM M 
reads per sample (Dataset S1).  
 
Bulk RNA expression quantification 
RNA-seq reads were trimmed by Trimmomatic v0.39 (24) and aligned to the RefSeq Mus musculus 
transcriptome (GRCm38) using HISAT2 (25). The resulting transcriptome alignments were sorted 
by SAMtools (26) and processed using the RNA-Seq by HTSeq (27) to estimate expected counts 
over RefSeq transcripts.  
 
Bulk RNA-seq data analysis 
Counted files were normalized and analyzed by R language package DESeq2 v1.28.1 (28). Genes 
with expression count below 5 in all samples were filtered out. Differential Expression (DE) genes 
were calculated by DESeq2 v 1.28.1 with Wald test. The DE genes were visualized in venn 
diagrams and volcano plots with the R packages VennDiagram and EnhancedVolcano (13). 
 
Semi-quantitative (q)PCR  
Vβ11+CD4+ T cells were sorted as described. Amplified cDNA was generated using a modified 
version of the SmartSeq2 protocol (23) during the Bulk RNA-seq process (see above). The 
following material was used according to the manufacturer’s protocol: Mastermix: Maxima 
Probe/ROX qPCR MM (2x) (Thermo Fisher), housekeeping gene Gapdh (Mm99999915_g1, VIC-
MGB_PL labelled, TaqMan); tested TaqMan gene expression assays (FAM-MGB labelled): Bcl6 
(Mm00477633_m1), Lta (Mm00440228_gH), Ltb (Mm00434774_g1), Il17a (Mm00439618_m1).  
 
Collection of Cerebrospinal fluid and proteomics of chemokines and immunoglobulin isotypes 
Cerebrospinal fluid (CSF) was collected from mice as described (29). Mice were anesthetized at 
peak of EAE with intraperitoneal Ketamine / Xylazine. After removal of the hair and covering any 
pressure points of the skull with 2% xylocaine gel, the head of the mice was mounted in a 
stereotaxic apparatus (ASI Instruments) via ear bars (29). Under a dissecting binocular microscope, 
the skin and muscles were bluntly separated to expose the cisterna magna. The cisterna magna 
was exposed as a glistening and triangular shape (30, 31). Using the micromanipulators, the 
cisterna magna was punctured with a 30G blunt end Hamilton syringe and CSF was collected by 
pulling the piston back carefully. On average 15.92 μl +/- 1.58 SEM were collected from one mouse 
(Dataset S20). Samples were discarded if visibly red which indicated blood contamination. Mice 
were sacrificed afterwards.  
The collected CSF was briefly centrifuged at 4°C, the supernatant was collected in low protein 
binding tubes, stored frozen at -80 °C until further processing. Detection of cytokines and 
chemokines was performed using the Bio-Plex Pro mouse chemokine panel 31-plex (Bio-Rad 
Laboratories, Hercules, CA) and analyzed by the Luminex FLEXMAP 3D platform as previously 
reported (32). Concentrations of CSF analytes were transformed logarithmically for graphing and 
statistical analysis purposes. Curve fitting was performed using Milliplex Analyst 5.0 software 
(VigeneTech.com). 
Immunoglobulin (Ig) isotypes in CSF were evaluated using the ThermoFisher (Invitrogen) Antibody 
Isotyping 7-Plex Mouse ProcartaPlex™ Panel according to manufacturer’s instructions. Briefly, 





washed capture beads, 25 µl of the diluted sample was incubated for 1 hour at RT under continuous 
shaking (600 rpm). After washing steps on a magnet, the plate was incubated with isotyping 
detection antibody mix for 30 min at room temperature (600 rpm) and subsequently washed with a 
magnet. Read buffer was added and the plate was run on the Luminex® FLEXMAP 3D® detection 
instrument operated with xPONENT Software V4.2 (Luminex Corp., Austin, TX). Fifty beads per 
region for each bead were analyzed for mean fluorescence intensity (MFI) and compared to a 7-
point standard curve. A 5-parameter curve fit algorithm was applied to the data using Belysa version 
1.1.0 software (Merck EMD Millipore, Billerica, MA) to calculate the concentration of each analyte. 
 
Immunofluorescence stainings (IF) 
We used two different approaches for immunofluorescence stainings (IF) and histological analysis: 
1) IF of whole spine cross-sections, and 2) frozen IF. The first approach was optimized to maintain 
the anatomy of whole spine cross-sections including intact meninges and to reduce the 
susceptibility of the tissue for changing its size during processing through protection by spinal 
bones. This approach was therefore suitable for quantification and localization in semi-quantitative 
heatmaps. The second approach was optimized for visualizing specific cell agglomerates at higher 
magnification and at improved feasibility of multi-color IF staining and optimized morphology. This 
was based on cryo sections which improve tissue conservation and multi-marker stainings. 
 
Whole-spine cross-section IF 
At peak of adoptive transfer EAE, mice were sacrificed for whole-spine histology as previously 
described (33, 34). Mice were perfused intracardially with PBS, followed by perfusion with 4% PFA. 
Spinal cord (SC) was dissected together with the surrounding bone. The tissue was fixed overnight 
in 4% PFA and then decalcified for seven days in 0.3 M EDTA solution. After 2-3 days the EDTA 
solution was changed once. The tissue was then cryoprotected with a 30% sucrose solution for at 
least two days. Cross-sections of the SC (10-µm thickness) were cut at the cervical, thoracic and 
lumbar level with a cryostat (Cryostar NX50) at -23 °C. After tissue blocking, the following primary 
antibodies were used for staining: hamster anti-mouse CD3 (clone 500A2, BD Bioscience, 1:30), 
rat anti-mouse FITC TCR Vβ11 (clone KT11, BioLegend, 1:50), rat anti-mouse B220 (clone RA3-
6B2, Invitrogen, 1:200) and rat anti-mouse F4/80 (clone CI:A3-1, Serotec, 1:500). B220 staining 
was done with biotin-conjugated goat anti-rat IgG (Abcam, 1:200). F4/80 staining was enhanced 
using biotin-conjugated rabbit anti-rat IgG (Vector Labs, 1:200), streptavidin-horseradish 
peroxidase (Biolegend, 1:100) and tyramide (AdipoGen, 1:100 in elution buffer). For visualization 
the following fluorescent secondary antibodies were used: goat anti-rat IgG AF488 (ThermoFisher, 
1:50), goat anti-hamster IgG AF594 (ThermoFisher, 1:50), streptavidin-conjugated AF488 
(ThermoFisher, 1:100), streptavidin-conjugated AF594 (ThermoFisher, 1:100) and donkey anti-
rabbit IgG AF594 (Life, 1:50). All antibodies were diluted in blocking reagent (Roche). Nuclei were 
stained by 4′,6-diamidino-2-phenylindole (DAPI) (included in used mounting medium Fluoromount-
G with DAPI from Invitrogen). For intracellular Ki67 (rabbit anti-mouse, #ab15580, Abcam, 1:50) 
staining, cross-sections were permeabilized with 0.1% Triton before antibody staining. Ki67 
staining was combined with labelled rat anti-mouse B220-AF488 (clone RA3-6B2, BD, dilution 
1:100) and was otherwise done as described above. 
We aimed to quantify infiltration by different cell types (B220+, F4/80+, CD3+ and Vβ11+ cells) at the 
cervical, thoracic and lumbar levels of the SC. To measure the whole compartment area (meninges 
& parenchyma), all stained sections were photographed (10x magnification) and the pictures were 
merged using BZ-Analyzer II (Keyence) to create overview pictures. The meninges were identified 
by their morphological structure between bone and parenchyma. The polygon and measurement 
functions of ImageJ were used to manually measure the compartment area from the overview 





percentage of infiltrated area was determined by calculating the ratio between the total area of the 
compartment (meninges & parenchyma) and the infiltrated area of B220+ and F4/80+ cells 
contained in the compartment. The absolute number of CD3+ and Vβ11+ cells was counted 
manually in the compartments (meninges & parenchyma) on cervical, thoracic and lumbar level on 
the fluorescence microscope Nikon Eclipse 80i (40x magnification). To determine the absolute cell 
count of Ki67+B220+ cells, images of stained sections on lumbar level were taken with an apotome 
(Zeiss) in 20x magnification and cells were counted manually. The density of the infiltrated CD3+, 
Vβ11+ and Ki67+B220+ cells in the compartments [cells/mm2] was determined by dividing the 
counted cells in each compartment by the area of that compartment. 
Heatmaps were generated to map the localization of the different cell types. The heatmaps 
represent a schematic representation of the SC. Afterwards, heatmaps of the individual test mice 
were overlaid. The opacity of the infiltrates of the individual animals was calculated using the 
formula (100% / n) x 4. The digital editing was done with Adobe Illustrator CS6. 
 
Frozen IF 
At the peak of AT-EAE, mice were sacrificed, and spinal cord parenchyma enveloped in meninges 
was carefully isolated (without destroying the connected meningeal tissue). The tissue was directly 
frozen in Tissue-Tek O.C.T.TM compound (Sakura Finetek Europe) and stored at -80 °C until 
cutting. 8 µm longitudinal sections were cut at -20 °C using a cryotome (Microm International 
GmbH). Staining was performed as previously described (35, 36). Briefly, tissue was fixed in -20°C 
methanol for 10 minutes before the staining procedure and blocked in 1% BSA in PBS. Primary 
antibodies used for staining were rat anti-mouse B220-FITC or -AF488 (clone RA3-6B2, BD, 
dilution 1:100), rat anti-mouse B220 (unlabelled, clone RA3-6B2, eBiosciences, 1:50), rat anti-
mouse TCR Vβ11-FITC or -APC (clone KT11, BioLegend, 1:100), rat anti-mouse CD4-APC (clone 
L3T4, eBioscience, 1:100), rat anti-mouse CD45.2 (clone 30G12, conditioned Medium, (37), 
undiluted), rabbit anti-mouse Laminin-111 ‘pan laminin’ (38), Serum, 1:500), goat anti-mouse 
CXCL13 (R&D Systems, 1:50), rat anti-mouse ER-TR7 (clone ER-TR7, Dianova, 1:100). As 
secondary antibodies, donkey anti-rat IgG AF555 (1:3000), donkey anti-rat IgG AF647 (1:1000), 
donkey anti-rabbit IgG AF647 (1:1000), donkey anti-goat IgG AF594 (1:1000), donkey anti-rat IgG 
AF488 (1:1000), donkey anti-rabbit IgG AF594 (1:1000) were used. Nuclei were stained with DAPI 
and stained sections were mounted with Mowiol 488 (25% (w/v) in 1x PBS). Sections for high 
magnification were microscoped with Zeiss AxioImager (Software: Volocity 6.3 (PerkinElmer)). 
Overview pictures were acquired with a Zeiss LSM 700 confocal microscope using the ZEN 
grey/blue software (Zeiss).  
 
In vitro Th17 polarization and proliferation of CD4+ T cells isolated from EAE mice 
CD4+ T cells and CD11c+ dendritic cells (DCs) were isolated from draining lymph nodes and spleen 
on day 10 after immunization with MOG35-55 using magnetic beads (Miltenyi Biotec, anti-mouse 
CD4 (clone: L3T4) MicroBeads and anti-mouse CD11c UltraPure MicroBeads). CD4+ T cells and 
CD11c+ DCs were co-cultured in a 5:1 ratio in the presence of MOG35-55 (20 μg/ml) on a round-
bottom 96-well plate coated with anti-CD3 (0.5 µg/ml). For proliferation assays, CD4+ T cells were 
additionally stained with CellTrace™ Violet (Thermofisher) according to manufacturer’s 
instructions, and T cell proliferation was analyzed by flow cytometry. For Th17 polarization, TGF-
β1 (10 ng/ml), IL-6 (20 ng/ml) and anti-IFN-γ (10 µg/ml) was added to the culture for 4 days, and 









In vitro B cell proliferation 
MOG-specific CD19+ B cells were isolated with MicroBeads (Miltenyi Biotec, anti-mouse CD19 
MicroBeads) from the spleen and inguinal lymph nodes of a naïve TH mouse (synonymously 
IgHMOG mouse, (5); containing a MOG-specific B cell receptor) and labeled with cell proliferation 
dye Cell Trace Violet (Thermofisher) according to manufacturer’s instructions. Labeled B cells were 
cocultured in a 2:1 ratio with in vitro differentiated Th17 cells from 2D2tg mice with MOG35-55 peptide 
(3 µg/ml). Th17 had been differentiated as in AT-EAE (see above). On day 3, B cell proliferation 
was analyzed by flow cytometry. 
 
Statistics  
Data are presented as box-and-whisker plots (Tukey method) combined with dot plots. The hinges 
of the box extend from the 25th to 75th percentiles (= interquartile range, IQR), the horizontal line 
inside the box indicates the median, and the whiskers extend to the most extreme values within the 
1.5 IQR of the lower and upper quartile. Dots illustrate the individual values. Data were compared 
using two-tailed Student’s t-test for unrelated samples. If the F-test of equality of variances was 
significant, the two-tailed Mann-Whitney U test was applied. p-value < 0.05 was considered 
significant. The correlation analysis for normally distributed data (checked by Shapiro-Wilk and 
Kolmogorov-Simnov) was carried out with the one-tailed Pearson test. Otherwise, the Spearman 
test was used. GraphPad Prism 5 was used for statistical analysis of quantifications of flow 
cytometry, immunohistochemistry, qPCR, and CSF proteomics data. Statistical analysis of 
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Figure S1: Representative gating strategies of FACS and flow cytometry. 
(A) Representative gating of the indicated cell types in the meninges (men) and (B) the parenchyma 
(par) of the spinal cord of recipients of wild type 2D2tg Th17 donor cells (wt-R) to identify main 
lineages and to flow sort for CD45ivneg tissue-resident viable leukocytes (TRL) - either CD45high 
leukocytes for scRNA-seq or Vβ11+ CD4+ T cells (Tc) for bulk RNA-seq. Abbreviations: scRNA-seq 
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Figure S2: Combined cell cluster characterization and annotation. 
(A) CD45ivnegCD45high tissue-resident leukocytes (TRL) were flow sorted from the spinal cord 
meninges (men) and parenchyma (par) of recipients of wild type (wt) 2D2tg Th17 donor cells (wt-
R) and processed by single cell RNA-sequencing (scRNA-seq). Single cell transcriptomes from two 
combined samples (wt-R-men: 4,068 cells, wt-R-par: 4,071 cells) are depicted in a Uniform 
Manifold Approximation and Projection (UMAP) plot. Clusters are classified and outlined as B cells 
(Bc; green), CD4+ T cells (CD4; orange), CD8+ T and natural killer cells (cyto; blue), and myeloid 
cells (grey). Description of all Bc and CD4 clusters as in Fig. 1B (Results). Cytotoxic and myeloid 
clusters were defined as followed: Six clusters were assigned to cytotoxic cell types (cyto) and 
represented CD8 T cells (Cd3e, Cd8a, Ccl5, Nkg7), cytotoxic T lymphocytes (CTL; Cd3e, Nkg7) 
and two types of natural killer (NK) cells (Nkg7, Cd3eneg, Prf1, Gzma). Eight myeloid lineage 
clusters represented plasmacytoid dendritic cells (pDC; Siglech), two clusters of granulocytes 
(granulo-1/granulo-2; S100a8, Lcn2), classical dendritic cells (cDC; Clec9a, Cst3, Cd74/MHC class 
II chain) and meningeal dendritic cells (menDC; Fscn1, Ccr7, Cst3). Others resembled microglia 
(micro; Hexb, Tmem119) and two further myeloid clusters (myeloid-1/-2; Lyz2, Cd14, Fcgr3/CD16) 
as described (39, 40). (B) Dotplot of selected marker genes for main leukocyte lineages in the 
combined dataset as in A. (C) Feature plots of selected marker genes for main leukocyte lineages. 
(D) Scheme illustrating the clustering and cell classification approach. The initial 24 cell clusters 
were classified into 4 cell types and B cells were further sub-clustered. All CD4 clusters and all 
Th17 clusters, respectively, were merged for deeper transcriptomic analysis depicted in Fig. S3A-
B. All clusters identified as CD4+ T cells were subset into cells expressing the 2D2tg T cell receptor 
(TCR) or expressing other non-2D2tg TCRs. 
Abbreviations: Bc B cells, diffBc differentiated B cells, CD4 CD4+ T cells, act activated, Th17 Th17 
cells, Treg regulatory T cells, proli proliferating, exh exhausted, CD8 CD8+ T cells, CTL cytotoxic T 
lymphocytes, NK natural killer cells, prolicyt proliferating cytotoxic T lymphocytes, granulo 
granulocytes, micro microglia, DC dendritic cells, menDC meningeal DC, pDC plasmacytoid DC, 




























-Log10 adj p-value 































higher in wt-R-par higher in wt-R-men
scRNA-seq CD4 merge B
higher in wt-R-par higher in wt-R-men
scRNA-seq Th17 merge ns
-Log10 
adj p−value
-Log10 adj p-value 



















































D bulk RNA-seq 9ȕ+ 
210-1-2










TCR as representative for whole cDNA Enrichment of 
single cell TCR
Sequencing library 


































whole cDNA TCR specific 
E
375 - 1475 nt






























































































































































































Figure S3: The meningeal vs. parenchymal microenvironment induces a site-specific CD4+ T cell 
phenotype in neuroinflammation. 
(A) Single cell transcriptomes of AT-EAE wt-R (Fig. 1B) and identified as CD4+ T cells (actCD4, 
proliCD4, proliTreg, Treg, exhCD4, Th17-1, Th17-2, proliTh17) or as (B) Th17 cells (Th17-1, Th17-
2, proliTh17) were combined, and genes differentially expressed (DE) between meninges (men) 
and parenchyma (par) (Dataset S3-4) were depicted as volcano plots. Genes beginning with ‘Mt’ 
and ‘Rp’ were removed. Thresholds for significant genes were set at average (avg) log Fold Change 
(FC) > 0.02 and -Log10 adjusted (adj) p-value < 1E-05. (C) Gene score plots of selected genes 
characteristic for Th17-1 (left) or Th17 cells (right) in men and par (Dataset S5). Black border line 
highlights CD4+ T cells. (D) Vβ11+CD4+CD45ivnegCD45high cells were sorted from men and par of 
the SC of a wt-R at peak AT-EAE (illustrated in Fig. 1A) and processed by bulk RNA-sequencing. 
Bar plots of genes DE in Vβ11+ wt-R-men vs. Vβ11+ wt-R-par (Dataset S6). (E) ‘Circularization’ 
protocol for obtaining antigen receptor information from 3’ scRNA-seq (Suppl. Methods). The first 
circularization step is completed for the whole cDNA from scRNA-seq library, the second 
circularization step (after enrichment of single cell T cell receptor (TCR)) is TCR-specific. The result 
is a substantial shortening of the TCR constant region enabling sequencing of the TCR variable 
region. (F) UMAP plot with CD4+ T cells expressing the 2D2tg TCR in wt-R-men (left) and wt-R-par 
(right). (G) UMAP plot of CD4+ T cells expressing any non-2D2tg TCR in wt-R-men (left) and wt-R-
par (right). (H) Comparison of the proportion of 2D2 cells: Vβ11+CD4+ of CD45high tissue-resident 
leukocytes (TRL) in wt-R-men vs. wt-R-par quantified by flow cytometry (left), and 2D2tg TCR 
expressing CD4+ T cells determined by TCR sequencing related to all leukocytes (CD45high), i.e. all 
cells included in the scRNA seq dataset (middle). Right: proportion of Vβ11+ of viable CD4+ (TRL) 
quantified by flow cytometry. TRL analyzed by flow cytometry or scRNA seq were isolated from SC 
meninges and parenchyma of wt-R (peak AT-EAE). (I) Stacked bar-plots of the proportion of 2D2tg 
TCR and non-2D2tg TCR within selected CD4 clusters (with high proportion of 2D2tg TCR 
expressing cells) in wt-R-men vs. wt-R-par. CD4+ T cells were classified by single cell 
transcriptomes; 2D2tg TCR cells by the expression of the known 2D2tg TCR α/β-sequence and a 
sufficient expression of the Trac/Trbc mRNA.  
Abbreviations:  AT-EAE adoptive transfer experimental autoimmune encephalomyelitis, wt-R wild 











































































































































































Figure S4: B cells and donor-derived CD4 T cells colocalize in spinal cord meninges of AT-EAE 
recipient mice. 
(A-B) Representative immunofluorescence staining of parallel freshly frozen SC longitudinal 
sections (Methods) of a AT-EAE recipient (wt-R) mouse at peak of disease stained for the indicated 
markers. Scale bars indicate 100 µm. Overview pictures on the left and right side include a 
magnification box indicating the exact location of the enlarged section shown in different color 
combinations. PLM pan laminin marker (Methods). This Suppl. Fig. is related to Fig. 1H. (C) 
Heatmap (left) represents the localization of B220+ areas and Vβ11+CD3+ cells in a lumbar cross-
section of one representative AT-EAE recipient (wt-R) mouse at peak of disease. Dot plots 
depicting correlations between Vβ11+ and B220+ cell densities in the meninges (men; middle) (top; 
r=0.62, R2=0.38, p=0.03), however not in the parenchyma (par; right) of AT-EAE recipients (wt-R). 
(D) Dotplots depicting lacking correlations between Vβ11+ and F4/80+ cell densities in the men (left; 
r=0.42, R2=0.18, p=0.12) and par (right; r=0.28, R2=0.17, p=0.22) of wt-R. Straight line represents 
the linear regression line with its confidence interval in grey in C and D.  
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Figure S5: Histology confirms that Bcl6 differentially affects T cells and B cells in 
neuroinflammation. 
(A) Recipient (-R) mice of 2D2tg (wild type (wt), black circles, n = 6) and CD4CreBcl6fl/fl2D2tg (Bcl6KO, 
green squares, n = 8) were monitored for signs of AT-EAE (scheme of experimental set-up 
described and depicted in Fig. S5E). One representative out of five independent experiments is 
shown. Adapted from (4) in accordance with the Creative Commons license “CC BY 4.0” 
(https://creativecommons.org/licenses/by/4.0/). (B) Proportion of CD19+ CD3- B cells of CD45high 
leukocytes isolated from the brain and spinal cord (SC). Parenchymal and meningeal tissues were 
not separated here. Adapted from (4), which is licensed under CC BY 4.0. (C) In vitro differentiated 
Th17 cells from wild type (wt) 2D2tg donors or from CD4CreBcl6fl/fl2D2tg (Bcl6KO) donors 
immediately before adoptive transfer (Fig. 1, Fig. S5E) were re-stimulated for 4 hours with 
PMA/ionomycin and stained for intracellular cytokines. Adapted from (4), which is licensed under 
CC BY 4.0. (D) Wt or CD4CreBcl6fl/fl (Bcl6KO) mice were immunized with MOG35-55 and after 10 
days, CD4+ T cells were isolated from iLN and spleen, labeled with Cell Trace Violet, and co-
cultured for 4 days with CD11c+ and MOG35-55 (Methods). T cell proliferation was analyzed by flow 
cytometry. (E) Scheme illustrating the experimental approach: Naïve CD44lowCD62LhighCD4+ T 
cells (violet) were sorted from 2D2tg (wt) and 2D2tg  CD4cre Bcl6fl/fl (Bcl6KO) donor mice and 
differentiated in vitro into Th17 donor cells (orange) with TGF-β1/IL-6 followed by IL-23 (41). These 
were intravenously (iv) injected into C57BL/6 recipient (=R) mice (= wt-R / Bcl6KO-R) to induce 
adoptive transfer experimental autoimmune encephalomyelitis (AT-EAE; Methods). At maximum 
AT-EAE severity, phycoerythrin (PE) labelled anti-CD45 antibody (3 µg/mouse) was iv injected and 
leukocytes were separately extracted from the meninges (men; top) and parenchyma (par; bottom) 
of the SC. CD45ivnegCD45high cells were defined as tissue-resident leukocytes (TRL) and flow 
sorted for single cell RNA-sequencing (scRNA-seq) and Vβ11+CD4+CD45ivneg T cells (Tc) were 
sorted for bulk RNA-seq and qPCR (Methods; sorting strategy shown in Fig. S1). (F) Stacked bar-
plots of the proportions of cell types classified in Fig. 1B and Fig. 2D in wt-R-men and Bcl6KO-R-
men (upper panels) and wt-R-par and Bcl6KO-R-par (bottom panels). (G) Proportion of Vβ11+ cells 
of viable CD4+CD45ivnegCD45high TRL in the meninges of wt-R (black open circles) and Bcl6KO-R 
(green open squares) was quantified by flow cytometry. (H) Proportion of CD11b+ cells of viable 
CD45ivnegCD45high TRL in the meninges of wt-R and Bcl6KO-R was quantified by flow cytometry 
(left). Proportion of F4/80 infiltrated area in the meninges of wt-R and Bcl6KO-R (right) was 
quantified by IF (Methods). (I) Frozen PFA-fixed cross-sections of the SC inside the decalcified 
vertebrae were stained by immunofluorescence. The area occupied by B220+ (left) and F4/80+ cells 
(right) and the number of Vβ11+CD3+ and CD3+ cells (middle) were quantified and localized 
manually (Methods). Heatmaps represent overlays of n = 10 wt-R mice (upper panels) and n = 7 
Bcl6KO-R mice (bottom panels) of lumbar SC sections in every panel. (J) UMAP plot depicting 
single cell transcriptomes of TRL extracted from SC parenchyma (par) of wt-R (wt-R-par, 4,071 
cells) and Bcl6KO-R (Bcl6KO-R-par, 4,279 cells). (K) Bi-directional bar-plots showing differences 
of cluster proportions in Bcl6KO-R-par vs. wt-R-par. Positive values indicate higher abundance in 
the Bcl6KO-R-par. (L) Proportions of the indicated cell types were quantified by flow cytometry of 
viable CD4+CD45ivnegCD45high TRL or of viable CD45ivnegCD45high TRL in the parenchyma of wt-R 
(closed black circles) and Bcl6KO-R (closed green squares). Gating of flow cytometry analyses (G-
H, L) as in Fig. 1E and Fig. S1. (M) Quantification of % area occupied by B220+ (left) and F4/80+ 
cells (right), or the density of Vβ11+CD3+ and CD3+ cells (middle) in SC parenchyma of wt-R and 
Bcl6KO-R as in I. Each dot represents the mean of three SC sections per mouse. Median, 25th-to-
75th percentiles, and 1.5-fold interquartile range indicated in G-H, L-M. Student’s t-test was used 
for all normally distributed datasets, otherwise Mann-Whitney-U test was used (Methods). * p < 
0.05, ** p <0.01, *** p < 0.001, ns not significant.  
Abbreviations: AT-EAE adoptive transfer experimental autoimmune encephalomyelitis. 

































































































































































































































Figure S6: Bcl6 in Th17 cells changes the cell communication in spinal cord meninges in 
neuroinflammation. 
(A) Vβ11+CD4+CD45ivnegCD45high cells sorted from the meninges (men) or parenchyma (par) of the 
spinal cord (SC) of wild type (wt) and Bcl6KO recipients (-R) at peak AT-EAE were processed by 
bulk RNA-sequencing as in Fig. 2A (Fig. S5E), and meningeal- or parenchymal-specific 
differentially expressed (DE) genes between Bcl6KO-R and wt-R were calculated. Venn diagrams 
depict the number of up- (left) or downregulated (right) DE genes in Bcl6KO-R compared to wt-R 
(Dataset S15,16) in men (white circle), par (black circle) or in both men and par (grey circle). (B) 
Feature plots of selected genes in wt-R-men and Bcl6KO-R-men. (C) Volcano plot shows DE genes 
between Bcl6KO-R and wt-R in donor-derived cells sorted from the SC parenchyma (peak AT-
EAE) and analyzed by bulk-RNA sequencing as described in A. Thresholds were set at -Log10 
adjusted p value < 0.05 and log2FC > 0.75. (Dataset S15). (D) Single cell transcriptomes identified 
as B cells (Bc; Bc and diffBc cluster) were sub-clustered in wt-R-men (upper panel) and Bcl6KO-
R-men (bottom panel). Plots represent zoom out of comparative Uniform Manifold Approximation 
and Projection (UMAP) plots shown in Fig. 3B. (E) Violin plots depict selected Igh gene expression 
level in merged Bc from wt-R-men vs. Bcl6KO-R-men analyzed by single cell RNA-seq. One dot 
represents one single cell. (F) Feature plots of selected chemokine markers in wt-R-men (upper 
plots) vs. Bcl6KO-R-men (bottom plots). (G) Dot plot with selected chemokine receptors that can 
bind to the chemokine markers depicted in Fig. S6F in clusters identified as B cells and CD4 T cells 
in Fig. 1B and Fig. 2D. Upper dotplot shows marker expression in wt-R-men, bottom plot in Bcl6KO-
R-men. 
Abbreviations: log(2)FC log(2) fold change, Bc B cells, diffBc differentiated B cells, CD4 CD4+ T 












































































































































































































































































Figure S7: TCR sequencing identifies different proportions of donor-derived cells in the spinal cord 
meninges in wild type vs. Bcl6KO recipient mice. 
(A) Uniform Manifold Approximation and Projection (UMAP) plot with CD4+ T cells expressing the 
2D2tg TCR in the meninges (men) of recipient (-R) mice of wild type (wt) or Bcl6KO 2D2tg in vitro 
differentiated Th17 cells (wt-R (left) vs. Bcl6KO-R (right)). 2D2tg TCR cells (2D2) were detected 
with TCR sequencing (Methods; Fig. S3E-I) from tissue-resident leukocytes isolated from SC 
meninges (men) at peak of disease of AT-EAE (experimental scheme in Fig. 1A and Fig. S5E). (B) 
UMAP plot of CD4+ T cells expressing any non-2D2tg TCR in wt-R-men (left) and Bcl6KO-R-men 
(right). (C) Stacked bar-plots of the proportion of 2D2tg TCR and non-2D2tg TCR within selected 
CD4 clusters (with a high proportion of cells expressing the 2D2tg TCR) in wt-R-men vs. Bcl6KO-
R-men is depicted. CD4+ T cells were classified by single cell transcriptomes; 2D2tg TCR CD4+ T 
cells by the expression of the known 2D2tg TCR α/β-sequence and a sufficient expression of the 
Trac/Trbc mRNA (Methods). (D)  Feature plots of selected genes depicted in 2D2 (upper panels) 
and non-2D2 CD4 T cells (bottom panels) in wt-R-men and Bcl6KO-R-men. (E) Proportions of 
donor derived T cells of CD45ivnegCD45high tissue-resident leukocytes (TRL) detected with flow 
cytometry (Vβ11+ of CD45high; upper panel) and TCR-sequencing related to all cells detected with 
scRNA-seq (bottom panel) in wt-R-men vs. Bcl6KO-R-men. 
Abbreviations: AT-EAE adoptive transfer experimental autoimmune encephalomyelitis, CD4 CD4+ 
T cells, act activated, proli proliferating, Treg regulatory T cells, exh exhausted, Th17 Th17 cells; -


































































Figure S8: Bcl6-expressing Th17 cells can modulate a known local feed-forward loop in Th17 cells 
promoting meningeal neuroinflammation. 
(A) Secondary antibody control (ctrl) immunofluorescence staining (IF) for CXCL13 (Fig. 4D) of a 
spinal cord longitudinal section of a meningeal B cell aggregation in a representative wt-R at peak 
AT-EAE stained for the indicated markers (scale bars: 100 µm). (B) Scheme depicting potential 
interactions between encephalitogenic Th17 cells, follicular reticular cells (FRC)/stromal cells and 
follicular B cells in the meninges of AT-EAE recipient (wt-R-men) mice. We here integrate previous 
evidence (42, 43) and our data and hypothesize that the transcription factor Bcl6 promotes 
expression of Lymphotoxin-α and IL-17 in locally reactivated meningeal Th17 cells (Fig. 2C, H-J)  
which induces the production of B cell-supporting CXCL13 by meningeal stromal cells (42). Th17 










































Legends for Datasets S1-S26 
Dataset S1: Summary of technical information regarding samples and sequencing 
Technical information of all samples used for single cell RNA-sequencing (scRNA-seq), single cell 
T cell receptor repertoire sequencing (Circularization scTCR) and bulk RNA-sequencing (bulk RNA-
seq). Vβ11+ wt-Th17 and Vβ11+ Bcl6KO-Th17 samples are sorted Vβ11+CD4+ T cells from in vitro 
differentiated Th17 cells prior to intravenous injection for the induction of adoptive transfer (AT-) 
EAE. Vβ11+ wt-R-par, Vβ11+ Bcl6KO-R-par, Vβ11+ wt-R-men and Vβ11+ Bcl6KO-R-men samples 
are Vβ11+CD4+ T cells isolated from spinal cord meninges (men) or parenchyma (par) of wt or 
Bcl6KO AT-EAE recipient mice (wt-R or Bcl6KO-R). Abbreviations: wt wild type, Bcl6KO Bcl6 
knockout, men meninges, par parenchyma, Th17 Th17 cells. 
Dataset S2: Top expressed genes defining 24 clusters in scRNA-seq of merged sample (wt-R-
men, wt-R-par, Bcl6KO-R-men, Bcl6KO-R-par) 
Most frequently expressed genes (left) in all 24 clusters (right) identified in the first clustering 
performed with all cells (after doublet exclusion) from all four scRNA-seq samples (wt-R-men, wt-
R-par, Bcl6KO-R-men, Bcl6KO-R-par). Avg_logFC: log fold change of the average expression. 
Pct.1: The percentage of cells where the gene is detected in group1. Pct.2: The percentage of cells 
where the gene is detected in group2. P_val_adj: Adjusted p-value, based on bonferroni correction 
using all genes in the dataset. Abbreviations: scRNA seq single cell RNA sequencing, wt-R wild 
type recipient, Bcl6KO-R Bcl6 knockout recipient, men meninges, par parenchyma, Bc B cells, 
diffBc differentiated B cells, CD4 CD4+ T cells, act activated, Th17 Th17 cells, Treg regulatory T 
cells, proli proliferating, exh exhausted, CD8 CD8+ T cells, CTL cytotoxic T lymphocytes, NK natural 
killer cells, prolicyt proliferating cytotoxic T lymphocytes, granulo granulocytes, micro microglia, DC 
dendritic cells, menDC meningeal DC, pDC plasmacytoid DC, cDC classical DC, myeloid myeloid 
cells. 
Dataset S3: Differentially expressed genes of scRNA-seq data of CD4 merged in wt-R-men vs. wt-
R-par 
All clusters of scRNA-seq dataset identified as CD4 cells (Fig. 1B, Dataset S2,9, Fig. S2D; actCD4, 
proliCD4, proliTreg, Treg, exhCD4, Th17-1, Th17-2, proliTh17) were merged and most differentially 
expressed (DE) genes between wild type recipient (wt-R) meninges (men) and wt-R parenchyma 
(par) were calculated. Avg_logFC: log fold change of the average expression. Pct.1: The 
percentage of cells where the gene is detected in group1. Pct.2: The percentage of cells where the 
gene is detected in group2. P_val_adj: Adjusted p-value, based on bonferroni correction using all 
genes in the dataset. DE genes were calculated for all cell clusters with > 10 cells per sample. 
Abbreviations: scRNA seq single cell RNA sequencing, wt-R wild type recipient, men meninges, 
par parenchyma, CD4 CD4+ T cells, act activated, proli proliferating, Treg regulatory T cells, exh 
exhausted, Th17 Th17 cells. 
Dataset S4: Differentially expressed genes of scRNA-seq data of Th17 merged in wt-R-men vs. 
wt-R-par 
All clusters of scRNA-seq dataset identified as Th17 cells (Fig. 1B, Dataset S2,9, Fig. S2D; Th17-
1, Th17-2, proliTh17) were merged and most differentially expressed (DE) genes between wild type 
recipient (wt-R) meninges (men) and wt-R parenchyma (par) were calculated. Avg_logFC: log fold 
change of the average expression. Pct.1: The percentage of cells where the gene is detected in 
group1. Pct.2: The percentage of cells where the gene is detected in group2. P_val_adj: Adjusted 
p-value, based on bonferroni correction using all genes in the dataset. DE genes were calculated 





sequencing, wt-R wild type recipient, men meninges, par parenchyma, CD4 CD4+ T cells, proli 
proliferating, Th17 Th17 cells. 
Dataset S5: Genes included in gene scores for Th17-1 and Th17 cell type identification 
Gene lists used for gene scores shown in Fig. S3C to identify Th17-1 like cells and Th17 like cells, 
respectively, in single cell RNA-sequencing datasets. 
Dataset S6: Differentially expressed genes of bulk RNA-seq data of Vβ11+ wt-R-men vs. Vβ11+ 
wt-R-par 
Vβ11+CD4+ T cells isolated from spinal cord meninges (men) or parenchyma (par) of wt AT-EAE 
recipient (-R) mice were processed for bulk RNA seq. Differentially expressed (DE) genes from 
Vβ11+ wt-R-men vs. Vβ11+ wt-R-par are listed. BaseMean: The average of the normalized count 
values, dividing by size factors, taken over all samples. log2FoldChange: The effect size estimate, 
it indicates how much the gene or transcript's expression seems to have changed between the 
comparison and control groups. lfcSE: The standard error estimate for the log2 fold change 
estimate. Stat: The value of the test statistic for the gene or transcript. Pvalue: P-value of the test 
for the gene or transcript. Padj: Adjusted P-value for multiple testing for the gene or transcript (28). 
Abbreviations: seq sequencing, wt wild type, -R recipient, men meninges, par parenchyma. 
Dataset S7: 2D2 TCR cells and non-2D2 cells in scRNA-seq clusters 
1) Cell numbers detected by scTCRseq data before filtering. Cell numbers and proportions of any 
TCR α chain, any TCR β chain, 2D2 TCR α chain, 2D2 TCR β chain in Total, CD4 T cells (CD4 T 
cells are the clusters of actCD4, proliCD4, proliTreg, Treg, exhCD4, Th17-1, Th17-2 and proliTh17) 
or proliferating and activated CD4 T cells (proliCD4, actCD4) among all samples, wt-R samples, or 
Bcl6KO-R samples (after doublet exclusion). All TCR chains were collected before filtering and 
identified by their occurrence in scRNA-seq data. 2) Confident 2D2 cells and non-2D2 & non-T cells 
detected by scTCR sequencing (Methods) in all 24 clusters of scRNA-seq of wt-R-men, wt-R-par, 
Bcl6KO-R-men and Bcl6KO-R-par samples. Confident 2D2 T cells and non-2D2 & non-T cells were 
filtered as in the method. 3) Percentage of confident 2D2 T cells in Total, CD4 T cells or proliCD4 
and actCD4 among all samples, wt-R samples (wt-R-meninges [men] and wt-R-parenchyma [par] 
merged) or Bcl6KO-R (Bcl6KO-R-men and Bcl6KO-R-par merged) samples. Confident 2D2 T cells 
were filtered as in the method. Abbreviations: scRNA seq single cell RNA sequencing, wt-R wild 
type recipient, Bcl6KO-R Bcl6 knockout recipient, men meninges, par parenchyma, Bc B cells, 
diffBc differentiated B cells, CD4 CD4+ T cells, act activated, Th17 Th17 cells, Treg regulatory T 
cells, proli proliferating, exh exhausted, CD8 CD8+ T cells, CTL cytotoxic T lymphocytes, NK natural 
killer cells, prolicyt proliferating cytotoxic T lymphocytes, granulo granulocytes, micro microglia, DC 
dendritic cells, menDC meningeal DC, pDC plasmacytoid DC, cDC classical DC, myeloid myeloid 
cells. 
Dataset S8: Differentially expressed genes of 2D2 TCR cells vs. non-2D2 cells in merged CD4 T 
cell clusters in wt-R-men and wt-R-par merged 
Most differentially expressed (DE) genes in the merged CD4 T cell cluster (actCD4, proliCD4, 
proliTreg, Treg, exhCD4, Th17-1, Th17-2, proliTh17) in TCR sequencing data between 2D2-CD4 
T cells and non-2D2-CD4 T cells in wt recipient samples (wt-R-men and wt-R-par). 2D2-CD4 T 
cells and non-2D2-CD4 T cells filtering rule was described in Methods. Avg_logFC: log fold change 
of the average expression. Pct.1: The percentage of cells where the gene is detected in group1. 
Pct.2: The percentage of cells where the gene is detected in group2. P_val_adj: Adjusted p-value, 





(9) with default setting. Abbreviations: CD4 CD4+ T cells, act activated, proli proliferating, Treg 
regulatory T cells, exh exhausted, Th17 Th17 cells, TCR T cell receptor. 
Dataset S9: Cell number and percentage of 24 clusters and four cell lineages of four scRNA-seq 
samples 
At the peak of the AT-EAE an unbiased cell type clustering was performed from the meninges 
(men) and the parenchyma (par) of the wt and Bcl6KO recipients (wt-R and Bcl6KO-R). 24 
individual cell clusters (left) were identified and annotated based on top expressed genes (Dataset 
S2) and predefined marker gene-sets (Fig. 2 SA-C). Cell numbers of the 24 clusters (column 2-5) 
and the percentage of the clusters (column 6-9) within each of the four samples (wt-R-men, wt-R-
par, Bcl6KO-R-men, Bcl6KO-R-par) are listed. Clusters were classified into B cell (Bc), CD4+ T cell 
(CD4), cytotoxic (cyto), and myeloid cell lineages (Fig. 1B). Percentages of each lineage are 
depicted for every sample. Abbreviations: AT-EAE adoptive transfer EAE, scRNA seq single cell 
RNA sequencing, wt-R wild type recipient, Bcl6KO-R Bcl6 knockout recipient, men meninges, par 
parenchyma, Bc B cells, diffBc differentiated B cells, CD4 CD4+ T cells, act activated, Th17 Th17 
cells, Treg regulatory T cells, proli proliferating, exh exhausted, CD8 CD8+ T cells, CTL cytotoxic T 
lymphocytes, NK natural killer cells, prolicyt proliferating cytotoxic T lymphocytes, granulo 
granulocytes, micro microglia, DC dendritic cells, menDC meningeal DC, pDC plasmacytoid DC, 
cDC classical DC, myeloid myeloid cells. 
Dataset S10: Flow cytometry data in wt-R-men vs. wt-R-par 
Flow cytometry raw data from indicated populations in wt-R-men and wt-R-par as well as fold 
changes of selected cell populations between the indicated samples are depicted. Abbreviations: 
wt-R wild type recipient, men meninges, par parenchyma. 
Dataset S11: Quantification of histology data – T cells, B cells, macrophages 
Histology quantification data from indicated populations in wt-R-men, wt-R-par, Bcl6KO-R-men and 
Bcl6KO-R-par. Values describe the density of cells within the indicated compartment (men, par) of 
the sample. Depicted are for CD3+ and Vβ11+ CD3+ cells the cell density (cells / mm²) and for B220+ 
and F4/80+ cells the percentage of infiltrated area (% infiltrated area). Abbreviations: wt-R wild type 
recipient, Bcl6KO-R Bcl6 knockout recipient, men meninges, par parenchyma. 
Dataset S12: Differentially expressed genes of bulk RNA-seq data of in vitro Vβ11+ Bcl6KO-Th17 
vs. Vβ11+ wt-Th17 
Vβ11+ wt-Th17 and Vβ11+ Bcl6KO-Th17 samples are Vβ11+CD4+ T cells from in vitro differentiated 
Th17 cells prior to intravenous injection for the induction of adoptive transfer (AT-) EAE. Samples 
were processed for bulk RNA seq and differentially expressed (DE) genes from Vβ11+ Bcl6KO-
Th17 vs. Vβ11+ wt-Th17 samples are listed. Abbreviations: seq sequencing, wt wildtype, Bcl6KO 
Bcl6 knockout, Th17 Th17 cells, seq sequencing. 
Dataset S13: Flow cytometry data in Bcl6KO-R-men vs. wt-R-men 
Flow cytometry raw data from indicated populations in wt-R-men and Bcl6KO-R-men as well as 
fold changes of selected cell populations between the indicated samples are depicted. 
Abbreviations: wt-R wild type recipient, Bcl6KO-R Bcl6 knockout recipient, men meninges. 
Dataset S14: Flow cytometry data in Bcl6KO-R-par vs. wt-R-par 
Flow cytometry raw data from indicated populations in wt-R-par and Bcl6KO-R-par as well as fold 
changes of selected cell populations between the indicated samples are depicted. Abbreviations: 





Dataset S15: Differentially expressed genes of bulk RNA-seq data of Vβ11+ Bcl6KO-R-par vs. 
Vβ11+ wt-R-par 
Vβ11+CD4+ T cells isolated from spinal cord parenchyma (par) of wt or Bcl6KO AT-EAE recipient 
(-R) mice were processed for bulk RNA seq. Differentially expressed (DE) genes from Vβ11+ 
Bcl6KO-R-par vs. Vβ11+ wt-R-par are listed. Abbreviations: seq sequencing, wt wild type, Bcl6KO 
Bcl6 knockout, -R recipient, par parenchyma. 
Dataset S16: Differentially expressed genes of bulk RNA-seq data of Vβ11+ Bcl6KO-R-men vs. 
Vβ11+ wt-R-men 
Vβ11+CD4+ T cells isolated from spinal cord meninges (men) of wt or Bcl6KO AT-EAE recipient (-
R) mice were processed for bulk RNA seq. Differentially expressed (DE) genes from Vβ11+ 
Bcl6KO-R-men vs. Vβ11+ wt-R-men are listed. Abbreviations: seq sequencing, wt wild type, 
Bcl6KO Bcl6 knockout, -R recipient, men meninges. 
Dataset S17: Differentially expressed genes of scRNA-seq data of merged B cells in Bcl6KO-R-
men vs. wt-R-men 
Most differentially expressed (DE) genes in the merged Bc cluster (Fig. 3, Dataset S2,9, Fig. S2D) 
in scRNA seq data between Bcl6KO-R-men vs wt-R-men. Avg_logFC: log fold change of the 
average expression. Pct.1: The percentage of cells where the gene is detected in group1. Pct.2: 
The percentage of cells where the gene is detected in group2. P_val_adj: Adjusted p-value, based 
on bonferroni correction using all genes in the dataset. Abbreviations: scRNA seq single cell RNA 
sequencing, wt-R wild type recipient, Bcl6KO-R Bcl6 knockout recipient, men meninges, par 
parenchyma, Bc B cells, diffBc differentiated B cells. 
Dataset S18: Marker genes of five B cell subclusters in scRNA-seq data in Bcl6KO-R-men and wt-
R-men 
Most frequently expressed genes in the five Bc subclusters (Bc1, Bc2, Bc3, FOBc, PC) in Bcl6KO-
R-men and wt-R-men are listed. All cells identified as B cells in scRNA-seq data in Bcl6KO-R-men 
and wt-men-R were merged (Fig. 1B, Dataset S2,9, Fig. S2D) and then sub-clustered with higher 
resolution. Avg_logFC: log fold change of the average expression. Pct.1: The percentage of cells 
where the gene is detected in group1. Pct.2: The percentage of cells where the gene is detected 
in group2. P_val_adj: Adjusted p-value, based on bonferroni correction using all genes in the 
dataset. Abbreviations: scRNA seq single cell RNA sequencing, wt-R wild type recipient, Bcl6KO-
R Bcl6 knockout recipient, men meninges, par parenchyma, Bc B cells, FOBc follicular B cells, PC 
plasma cells. 
Dataset S19: Cluster size of five Bc subclusters in scRNA-seq data in Bcl6KO-R-men and wt-R-
men 
A sub-clustering was performed from all meningeal B cell transcriptomes in scRNA-seq data and 
five B cell sub-clusters were identified (Bc1, Bc2, Bc3, FOBc, PC - left). Cell number in the five 
clusters (column 2+3) and the proportion of the clusters (column 4+5) within each of the two 
meninges samples (wt-R-men, Bcl6KO-R-men) are listed. Abbreviations: scRNA seq single cell 
RNA sequencing, wt-R wild type recipient, Bcl6KO-R Bcl6 knockout recipient, men meninges, par 
parenchyma, Bc B cells, FOBc follicular B cells, PC plasma cells. 
Dataset S20: Detailed results of immunoglobulin isotype concentrations measured in cerebrospinal 
fluid (CSF) 
Detailed results of immunoglobulin (Ig) isotype concentrations in the cerebrospinal fluid (CSF) 





(Methods) are depicted. CSF was taken at the peak of AT-EAE of sick wt and Bcl6KO recipients 
(wt-R and Bcl6KO-R). Dataset contains the exact concentrations per mouse of differentially 
abundant immunoglobulin isotypes (Fig. 3F) in wt-R and Bcl6KO-R and the volume of isolated CSF. 
Abbreviations: AT-EAE adoptive transfer EAE, wt wildtype, Bcl6KO Bcl6 knockout, -R recipient. 
Dataset S21: Quantification of histology data – Ki67+ B220+ cells. 
Histology quantification data from indicated populations in wt-R-men, wt-R-par, Bcl6KO-R-men and 
Bcl6KO-R-par. Values describe the density of cells within the indicated compartment (men, par) of 
the sample. Depicted is the cell density of Ki67+ B220+ cells (cells / mm²). Abbreviations: wt-R wild 
type recipient, Bcl6KO-R Bcl6 knockout recipient, men meninges, par parenchyma. 
Dataset S22: Detailed results of chemokines measured in cerebrospinal fluid (CSF) 
Detailed results of cerebrospinal fluid (CSF) proteomics measured by Bio-Plex Pro mouse 
chemokine panel 31-plex (Methods) are depicted. CSF was taken at the peak of AT-EAE of sick wt 
and Bcl6KO recipients (wt-R and Bcl6KO-R). Dataset contains names of cytokines that were 
screened and the exact concentrations per mouse of differentially abundant cytokines (Fig. 4A) in 
wt-R and Bcl6KO-R. Abbreviations: AT-EAE adoptive transfer EAE, wt wildtype, Bcl6KO Bcl6 
knockout, -R recipient. 
Dataset S23: TCR Sequencing Primers and 4 steps PCR program 
Technical information of T cell receptor (TCR) sequencing. TCR, T cell receptor. “R”, a purine base 
(arginine (A) or guanine (G)). “Y”, a pyrimidine base (cytosine (C) or thymidine (T)). “B”, a base of 
either C, G or T. 4 step PCR was used in TCR Repertoire enrichment. 2 annealing steps (63° C 
and 57 °C) were used due to the annealing temperatures’ difference between PolyA primer and 
TCR rev primers. Temperature was defined with degrees celsius (°C) and duration time in 
hh:mm:ss. 
Dataset S24: Differentially expressed genes of scRNA-seq data of all 24 clusters in wt-R-men vs. 
wt-R-par 
Differentially expressed (DE) genes between wild type recipients (wt-R) meninges (men) and wt-R 
parenchyma (par) in scRNA seq data were calculated. Avg_logFC: log fold change of the average 
expression. Pct.1: The percentage of cells where the gene is detected in group1. Pct.2: The 
percentage of cells where the gene is detected in group2. P_val_adj: Adjusted p-value, based on 
bonferroni correction using all genes in the dataset. DE genes were calculated for all cell clusters 
with > 10 cells per sample.  
Abbreviations: scRNA seq single cell RNA sequencing, wt-R wild type recipient, men meninges, 
par parenchyma. 
 
Dataset S25: Differentially expressed genes of scRNA-seq data of all 24 clusters in Bcl6KO-R-
men vs. wt-R-men 
Differentially expressed (DE) genes between Bcl6KO (Bcl6 knockout) recipients (Bcl6KO-R) 
meninges (men) and wild type recipients (wt-R) men in scRNA seq data were calculated. 
Avg_logFC: log fold change of the average expression. Pct.1: The percentage of cells where the 
gene is detected in group1. Pct.2: The percentage of cells where the gene is detected in group2. 
P_val_adj: Adjusted p-value, based on bonferroni correction using all genes in the dataset. DE 
genes were calculated for all cell clusters with > 10 cells per sample.  
Abbreviations: scRNA seq single cell RNA sequencing, wt wild type, Bcl6KO Bcl6 knockout, -R 






Dataset S26: Differentially expressed genes of scRNA-seq data of all 24 clusters in Bcl6KO-R-par 
vs. wt-R-par 
Differentially expressed (DE) genes between Bcl6KO (Bcl6 knockout) recipients (Bcl6KO-R) 
parenchyma (par) and wild type recipients (wt-R) par in scRNA seq data were calculated. 
Avg_logFC: log fold change of the average expression. Pct.1: The percentage of cells where the 
gene is detected in group1. Pct.2: The percentage of cells where the gene is detected in group2. 
P_val_adj: Adjusted p-value, based on bonferroni correction using all genes in the dataset. DE 
genes were calculated for all cell clusters with > 10 cells per sample. 
Abbreviations: scRNA seq single cell RNA sequencing, wt wild type, Bcl6KO Bcl6 knockout, -R 
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